These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of myogenic cell lines derived by 5-azacytidine treatment. Liu L; Harrington M; Jones PA Dev Biol; 1986 Oct; 117(2):331-6. PubMed ID: 2428680 [TBL] [Abstract][Full Text] [Related]
5. Effect of myogenic determination on tumorigenicity of chemically transformed 10T1/2 cells. Hustad CM; Jones PA Mol Carcinog; 1991; 4(2):153-61. PubMed ID: 1710465 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone promotes the differentiation of myoblasts and preadipocytes generated by azacytidine treatment of 10T1/2 cells. Nixon BT; Green H Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3429-32. PubMed ID: 6203122 [TBL] [Abstract][Full Text] [Related]
8. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Lassar AB; Paterson BM; Weintraub H Cell; 1986 Dec; 47(5):649-56. PubMed ID: 2430720 [TBL] [Abstract][Full Text] [Related]
9. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Wakitani S; Saito T; Caplan AI Muscle Nerve; 1995 Dec; 18(12):1417-26. PubMed ID: 7477065 [TBL] [Abstract][Full Text] [Related]
10. Effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Rosca AM; Burlacu A Stem Cells Dev; 2011 Jul; 20(7):1213-21. PubMed ID: 21067364 [TBL] [Abstract][Full Text] [Related]
11. Effects of complex extracellular matrices on 5-azacytidine-induced myogenesis. Scott-Burden T; Bogenmann E; Jones PA Exp Cell Res; 1986 Jun; 164(2):527-35. PubMed ID: 2423349 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD. Horwitz M Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953 [TBL] [Abstract][Full Text] [Related]
13. Alterations in differentiation and pyrimidine pathway enzymes in 5-azacytidine resistant variants of a myoblast line. Ng SK; Rogers J; Sanwal BD J Cell Physiol; 1977 Feb; 90(2):361-47. PubMed ID: 65357 [TBL] [Abstract][Full Text] [Related]
14. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Taylor SM; Jones PA Cell; 1979 Aug; 17(4):771-9. PubMed ID: 90553 [TBL] [Abstract][Full Text] [Related]
15. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Constantinides PG; Jones PA; Gevers W Nature; 1977 May; 267(5609):364-6. PubMed ID: 68440 [No Abstract] [Full Text] [Related]
16. Changes in phenotypic expression in embryonic and adult cells treated with 5-azacytidine. Taylor SM; Jones PA J Cell Physiol; 1982 May; 111(2):187-94. PubMed ID: 6177706 [TBL] [Abstract][Full Text] [Related]
17. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Liu Y; Song J; Liu W; Wan Y; Chen X; Hu C Cardiovasc Res; 2003 May; 58(2):460-8. PubMed ID: 12757880 [TBL] [Abstract][Full Text] [Related]
18. 5-azacytidine promotes the transdifferentiation of cardiac cells to skeletal myocytes. Kaur K; Yang J; Eisenberg CA; Eisenberg LM Cell Reprogram; 2014 Oct; 16(5):324-30. PubMed ID: 25090621 [TBL] [Abstract][Full Text] [Related]